Phospholamban Antikörper (Thr17)
-
- Target Alle Phospholamban (PLN) Antikörper anzeigen
- Phospholamban (PLN)
-
Bindungsspezifität
- Thr17
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Phospholamban Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS)
- Spezifität
- This antibody recognizes Human Phospholamban (Thr17).
- Aufreinigung
- Protein A column, followed by peptide affinity purification
- Immunogen
- KLH conjugated synthetic peptide selected from the Thr17 region of Human Phospholamban Genename: PLN
- Isotyp
- Ig Fraction
- Top Product
- Discover our top product PLN Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.25 mg/mL
- Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
- Target
- Phospholamban (PLN)
- Andere Bezeichnung
- Phospholamban (PLN Produkte)
- Hintergrund
- PLB is a 52 amino acid phosphoprotein which regulates the calcium pump of cardiac sarcoplasmic reticulum (SR). PLB is an oligomer of five identical subunits each having a cytoplasmic and transmembrane domain. The cytoplasmic domain (residues 1 to 25) contains the phosphorylation sites and is highly basic and readily cleaved by proteases, whereas the transmembrane domain (residues 25 to 52) is mostly hydrophobic, protease resistant and stabilizes the pentamer.Synonyms: Cardiac phospholamban, PLB, PLN
- Molekulargewicht
- 6109 Da
- Gen-ID
- 5350
- NCBI Accession
- NP_002658
- Pathways
- Negative Regulation of Transporter Activity
-